Valuation (55%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -18.09 | 9.60 |
| PEG Ratio (TTM) | -0.88 | -0.14 |
| P/S Ratio (TTM) | 1.68 | 5.04 |
| P/B Ratio (TTM) | 1.61 | 17.62 |
| P/FCF Ratio (TTM) | 8.32 | 20.11 |
| Price to 5YR AVG Earnings Ratio | 20.64 | 25.62 |
| Price to 5YR AVG FCF Ratio | 14.45 | 13.49 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -6.18% | 6.10% |
| ROE (TTM) | -8.75% | 55.50% |
| Net Profit Margin (TTM) | -9.26% | -165.99% |
| ROIC 5YR AVG | 27.88% | 5.00% |
Growth (83%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -42.82% | 183.64% | 106.85% |
| Revenue | 19.57% | 54.71% | 44.53% |
| Net Income | -42.88% | 191.58% | 111.67% |
| Cash Flow | 235.01% | 844.25% | 533.25% |
Health (60%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.45 | 1.50 |
| Quick Ratio (TTM) | 3.26 | 1.26 |
| D/E Ratio (TTM) | N/A | 1.53 |
| Interest Coverage (TTM) | N/A | 10.38 |
| Piotroski F-Score | 2 | 6 |
| Altman Z-Score | 4.26 | 4.95 |
| LTL to 5YR AVG FCF | 0.31 | 1.36 |
| Shares Outstanding Growth 5YR AVG | 2.23% | -0.15% |